MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE

Journal of Autoimmunity

Volumn 79, Issue , 2017, Pages 105-111

  Smith, Siobhán ^a   Fernando, Thilini ^b   Wu, Pei Wen ^b   Seo, Jane ^b   Ní Gabhann, Joan ^a   Piskareva, Olga ^a   McCarthy, Eoghan ^c   Howard, Donough ^c   O'Connell, Paul ^d   Conway, Richard ^d   Gallagher, Phil ^d   Molloy, Eamonn ^d   Stallings, Raymond L ^a   Kearns, Grainne ^b   Forbess, Lindsy ^b   Ishimori, Mariko ^b   Venuturupalli, Swamy ^b   Wallace, Daniel ^b   Weisman, Michael ^b   Jefferies, Caroline A ^a,b  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c BEAUMONT HOSPITAL   (Ireland)

^d ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

IFN signalling; IFN stimulated genes; MicroRNA; SLE

Indexed keywords

INTERFERON; INTERFERON REGULATORY FACTOR 9; MICRORNA; MICRORNA 302D; TRANSCRIPTION FACTOR EMX1; UNCLASSIFIED DRUG; ESTROGEN; IRF9 PROTEIN, HUMAN; MIRN302 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GENE EXPRESSION; HEK293 CELL LINE; HUMAN; HUMAN CELL; MONOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; CLUSTER ANALYSIS; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALS; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; ESTROGENS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE I; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICRORNAS; MONOCYTES; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 85015368237     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2017.03.003     Document Type: Article

References (30)

1. [1] Ronnblom, L., The importance of the type I interferon system in autoimmunity. Clin. Exp. Rheumatol. 34 (2016), 21–24 4 Suppl 98.
2. [2] Crow, M.K., Type I interferon in the pathogenesis of lupus. J. Immunol. 192:12 (2014), 5459–5468.
3. [3] O'Shea, J.J., Schwartz, D.M., Villarino, A.V., Gadina, M., McInnes, I.B., Laurence, A., The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu. Rev. Med. 66 (2015), 311–328.
4. [4] Lee, P.Y., Kumagai, Y., Li, Y., Takeuchi, O., Yoshida, H., Weinstein, J., Kellner, E.S., Nacionales, D., Barker, T., Kelly-Scumpia, K., et al. TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. J. Exp. Med. 205:13 (2008), 2995–3006.
5. [5] Thibault, D.L., Chu, A.D., Graham, K.L., Balboni, I., Lee, L.Y., Kohlmoos, C., Landrigan, A., Higgins, J.P., Tibshirani, R., Utz, P.J., IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. J. Clin. Invest. 118:4 (2008), 1417–1426.
6. [6] Lee, P.Y., Weinstein, J.S., Nacionales, D.C., Scumpia, P.O., Li, Y., Butfiloski, E., van Rooijen, N., Moldawer, L., Satoh, M., Reeves, W.H., A novel type I IFN-producing cell subset in murine lupus. J. Immunol. 180:7 (2008), 5101–5108.
7. [7] Lee, P.Y., Li, Y., Kumagai, Y., Xu, Y., Weinstein, J.S., Kellner, E.S., Nacionales, D.C., Butfiloski, E.J., van Rooijen, N., Akira, S., et al. Type I interferon modulates monocyte recruitment and maturation in chronic inflammation. Am. J. Pathol. 175:5 (2009), 2023–2033.
8. [8] Reeves, W.H., Lee, P.Y., Weinstein, J.S., Satoh, M., Lu, L., Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol. 30:9 (2009), 455–464.
9. [9] Feng, D., Yang, L., Bi, X., Stone, R.C., Patel, P., Barnes, B.J., Irf5-deficient mice are protected from pristane-induced lupus via increased Th2 cytokines and altered IgG class switching. Eur. J. Immunol. 42:6 (2012), 1477–1487.
10. [10] Inui, A., Ogasawara, H., Naito, T., Sekigawa, I., Takasaki, Y., Hayashida, Y., Takamori, K., Ogawa, H., Estrogen receptor expression by peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Clin. Rheumatol. 26:10 (2007), 1675–1678.
11. [11] Smith, S., Gabhann, J.N., McCarthy, E., Coffey, B., Mahony, R., Byrne, J.C., Stacey, K., Ball, E., Bell, A., Cunnane, G., et al. Estrogen receptor alpha regulates TRIM21 expression, contributing to dysregulated cytokine production in systemic lupus erythematosus. Arthritis Rheumatism 66:1 (2014), 163–172.
12. [12] Rider, V., Li, X., Peterson, G., Dawson, J., Kimler, B.F., Abdou, N.I., Differential expression of estrogen receptors in women with systemic lupus erythematosus. J. Rheumatol. 33:6 (2006), 1093–1101.
13. [13] Cunningham, M.A., Naga, O.S., Eudaly, J.G., Scott, J.L., Gilkeson, G.S., Estrogen receptor alpha modulates Toll-like receptor signaling in murine lupus. Clin. Immunol. 144:1 (2012), 1–12.
14. [14] Svenson, J.L., EuDaly, J., Ruiz, P., Korach, K.S., Gilkeson, G.S., Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse. Clin. Immunol. 128:2 (2008), 259–268.
15. [15] Kassi, E., Moutsatsou, P., Estrogen receptor signaling and its relationship to cytokines in systemic lupus erythematosus. J. Biomed. Biotechnol., 2010, 317452.
16. [16] Johansson, M.A.L., Moller, B., Smedby, T., Rantapaa-Dahlqvist, S., Oestrogen receptor α gene polymorphisms in systemic lupus erythematosus. Ann. Rheum. Dis. 64 (2005), 1611–1617.
17. [17] Panchanathan, R., Shen, H., Zhang, X., Ho, S.M., Choubey, D., Mutually positive regulatory feedback loop between interferons and estrogen receptor-alpha in mice: implications for sex bias in autoimmunity. PLoS One., 5(5), 2010, e10868.
18. [18] Dai, R., McReynolds, S., LeRoith, T., Heid, B., Liang, Z., Ahmed, S.A., Sex differences in the expression of lupus-associated miRNAs in splenocytes from lupus-prone NZB/W(F1) mice. Biol. Sex Differ., 4, 2013, 19.
19. [19] Hewagama, A., Gorelik, G., Patel, D., Liyanarachchi, P., Joseph McCune, W., Somers, E., Gonzalez-Rivera, T., The Michigan Lupus, C., Strickland, F., Richardson, B., Overexpression of X-Linked genes in T cells from women with lupus. J. Autoimmun. 41 (2013), 60–71.
20. [20] Fu, Q., Chen, X., Cui, H., Guo, Y., Chen, J., Shen, N., Bao, C., Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients. Arthritis Res. Ther., 10(5), 2008 R112-R.
21. [21] Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:4 (2001), 402–408.
22. [22] Murphy, A.J., Guyre, P.M., Wira, C.R., Pioli, P.A., Estradiol regulates expression of estrogen receptor ERalpha46 in human macrophages. PLoS One., 4(5), 2009, e5539.
23. [23] Xu, X., Veenstra, T.D., Concentration of endogenous estrogens and estrogen metabolites in the NCI-60 human tumor cell lines. Genome Med., 4(4), 2012, 31.
24. [24] Wickramasinghe, N.S., Manavalan, T.T., Dougherty, S.M., Riggs, K.A., Li, Y., Klinge, C.M., Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res. 37:8 (2009), 2584–2595.
25. [25] Lee, P.Y., Weinstein, J.S., Nacionales, D.C., Scumpia, P.O., Li, Y., Butfiloski, E., van Rooijen, N., Moldawer, L., Satoh, M., Reeves, W.H., A novel type I interferon-producing cell subset in murine lupus. J. Immunol. Baltim. Md 1950) 180:7 (2008), 5101–5108.
26. [26] Edgar, R., Barrett, T., NCBI GEO standards and services for microarray data. Nat. Biotechnol. 24:12 (2006), 1471–1472.
27. [27] Barrett, T., Edgar, R., Mining microarray data at NCBI's gene expression omnibus (GEO)*. Methods Mol. Biol. 338 (2006), 175–190.
28. [28] Chen, P., Vu, T., Narayanan, A., Sohn, W., Wang, J., Boedigheimer, M., Welcher, A.A., Sullivan, B., Martin, D.A., Ruixo, J.J., et al. Pharmacokinetic and pharmacodynamic relationship of AMG 811, an anti-IFN-gamma IgG1 monoclonal antibody, in patients with systemic lupus erythematosus. Pharm. Res. 32:2 (2015), 640–653.
29. [29] Baechler, E.C., Batliwalla, F.M., Karypis, G., Gaffney, P.M., Ortmann, W.A., Espe, K.J., Shark, K.B., Grande, W.J., Hughes, K.M., Kapur, V., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. 100:5 (2003), 2610–2615.
30. [30] Braun, D., Geraldes, P., Demengeot, J., Type, I., Interferon controls the onset and severity of autoimmune manifestations in lpr mice. J. Autoimmun. 20:1 (2003), 15–25.